{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:9297"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:9297","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Metabolite profiles in the investigation of childhood brain tumours","abstract":"Paediatric brain tumours are the leading cause of cancer mortality in 0-14 year olds. New diagnostic and prognostic tools are required, as are new therapeutic targets to improve survival. Metabolism is a powerful characterising feature of tumours, with potential to aid the management of these diseases. This thesis acquires metabolite profiles from paediatric brain tumour tissue, primarily by High Resolution Magic Angle Spinning NMR (HR-MAS), which are statistically analysed. Firstly, metabolite profiles obtained by HR-MAS were shown to accurately and robustly classify tissue from the three main cerebellar tumours. When compared to current histological intraoperative testing, metabolites profiles correctly diagnosed histologically ambiguous tumours. Secondly, survival analysis identified markers of prognosis. High glutamine concentration was associated with better clinical outcome both in terms of overall survival in a mixed tumour cohort and progression-free survival in a cohort of pilocytic astrocytomas. Finally, metabolic pathway analysis identified pathways altered by cerebellar tumours relative to each other, supported with mass spectrometry and independent gene expression data. Pathways identified include alanine, aspartate and glutamate metabolism, taurine and hypotaurine metabolism and glycine, serine and threonine metabolism. Considered together, this work provides strong reasoning for incorporating tissue metabolite profiles into clinical workflows for paediatric brain tumours.","abstract_html":"Paediatric brain tumours are the leading cause of cancer mortality in 0-14 year olds. New diagnostic and prognostic tools are required, as are new therapeutic targets to improve survival. Metabolism is a powerful characterising feature of tumours, with potential to aid the management of these diseases. This thesis acquires metabolite profiles from paediatric brain tumour tissue, primarily by High Resolution Magic Angle Spinning NMR (HR-MAS), which are statistically analysed. Firstly, metabolite profiles obtained by HR-MAS were shown to accurately and robustly classify tissue from the three main cerebellar tumours. When compared to current histological intraoperative testing, metabolites profiles correctly diagnosed histologically ambiguous tumours. Secondly, survival analysis identified markers of prognosis. High glutamine concentration was associated with better clinical outcome both in terms of overall survival in a mixed tumour cohort and progression-free survival in a cohort of pilocytic astrocytomas. Finally, metabolic pathway analysis identified pathways altered by cerebellar tumours relative to each other, supported with mass spectrometry and independent gene expression data. Pathways identified include alanine, aspartate and glutamate metabolism, taurine and hypotaurine metabolism and glycine, serine and threonine metabolism. Considered together, this work provides strong reasoning for incorporating tissue metabolite profiles into clinical workflows for paediatric brain tumours.","abstract_has_math":false,"creators":["Bennett, Christopher Daniel"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019-07","date_published":"2019-07","updated_at":"2026-11-19T09:30:39Z","subjects":["Q Science (General)","QH301 Biology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/9297/7/Bennett2019PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A9297","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["nihr","other"]},{"key":"dc:creator","label":"Author","values":["Bennett, Christopher Daniel"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2019-07-17"]},{"key":"dc:date.issued","label":"Date","values":["2019-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Cancer and Genomic Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/9297/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Q Science (General)","QH301 Biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/9297/7/Bennett2019PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Paediatric brain tumours are the leading cause of cancer mortality in 0-14 year olds. New diagnostic and prognostic tools are required, as are new therapeutic targets to improve survival. Metabolism is a powerful characterising feature of tumours, with potential to aid the management of these diseases. This thesis acquires metabolite profiles from paediatric brain tumour tissue, primarily by High Resolution Magic Angle Spinning NMR (HR-MAS), which are statistically analysed. Firstly, metabolite profiles obtained by HR-MAS were shown to accurately and robustly classify tissue from the three main cerebellar tumours. When compared to current histological intraoperative testing, metabolites profiles correctly diagnosed histologically ambiguous tumours. Secondly, survival analysis identified markers of prognosis. High glutamine concentration was associated with better clinical outcome both in terms of overall survival in a mixed tumour cohort and progression-free survival in a cohort of pilocytic astrocytomas. Finally, metabolic pathway analysis identified pathways altered by cerebellar tumours relative to each other, supported with mass spectrometry and independent gene expression data. Pathways identified include alanine, aspartate and glutamate metabolism, taurine and hypotaurine metabolism and glycine, serine and threonine metabolism. Considered together, this work provides strong reasoning for incorporating tissue metabolite profiles into clinical workflows for paediatric brain tumours."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Metabolite profiles in the investigation of childhood brain tumours"]}]}],"canonical_facts":{"dc:contributor.sponsor":["nihr","other"],"dc:creator":["Bennett, Christopher Daniel"],"dc:date":["2019-07-17"],"dc:date.issued":["2019-07"],"dc:description.abstract":["Paediatric brain tumours are the leading cause of cancer mortality in 0-14 year olds. New diagnostic and prognostic tools are required, as are new therapeutic targets to improve survival. Metabolism is a powerful characterising feature of tumours, with potential to aid the management of these diseases. This thesis acquires metabolite profiles from paediatric brain tumour tissue, primarily by High Resolution Magic Angle Spinning NMR (HR-MAS), which are statistically analysed. Firstly, metabolite profiles obtained by HR-MAS were shown to accurately and robustly classify tissue from the three main cerebellar tumours. When compared to current histological intraoperative testing, metabolites profiles correctly diagnosed histologically ambiguous tumours. Secondly, survival analysis identified markers of prognosis. High glutamine concentration was associated with better clinical outcome both in terms of overall survival in a mixed tumour cohort and progression-free survival in a cohort of pilocytic astrocytomas. Finally, metabolic pathway analysis identified pathways altered by cerebellar tumours relative to each other, supported with mass spectrometry and independent gene expression data. Pathways identified include alanine, aspartate and glutamate metabolism, taurine and hypotaurine metabolism and glycine, serine and threonine metabolism. Considered together, this work provides strong reasoning for incorporating tissue metabolite profiles into clinical workflows for paediatric brain tumours."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/9297/7/Bennett2019PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Cancer and Genomic Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/9297/"],"dc:subject":["Q Science (General)","QH301 Biology"],"dcterms:accessrights":["public"],"dc:title":["Metabolite profiles in the investigation of childhood brain tumours"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:30:39Z"}